| Table 11 |
| Patient Survival by Age at First Transplant and by Time
since Transplant |
| For Patients Receiving their First Transplant of this type
between 07/01/1996 and 06/30/2000 |
| Center: Shands Hospital at The University of Florida,
Gainesville, FL |
| Organ: LU: Lung
(Single-Organ Transplants Only) |
| |
|
|
|
|
|
|
|
|
|
|
Patient Survival by Time since First Transplant |
|
|
This Center |
|
United States |
|
|
1 Month |
1 Year |
3 Years |
|
1 Month |
1 Year |
3 Years |
| Adult (Age 18+) |
|
|
|
|
|
|
|
|
Transplants (n) 1 |
32 |
32 |
39 |
|
1,640 |
1,640 |
1,558 |
|
Patient Survival (%) 2 |
96.15 |
76.92 |
48.04 |
|
91.72 |
76.17 |
59.32 |
|
Expected Patient Survival (%) 3 |
92.09 |
74.37 |
53.99 |
|
NA |
NA |
NA |
|
P-value (2-sided) 4 |
0.785 |
0.922 |
0.274 |
|
NA |
NA |
NA |
|
Statistically different from expected |
Not Different |
Not Different |
Not Different |
|
NA |
NA |
NA |
|
Follow-up days reported (%) 5 |
71.9 |
45.8 |
70.3 |
|
92.4 |
85.4 |
91.4 |
|
Maximum Days of Follow-up (n) |
30 |
365 |
1,096 |
|
30 |
365 |
1,096 |
|
Follow-up forms filed (%) 6 |
100.0 |
100.0 |
100.0 |
|
99.7 |
99.6 |
98.7 |
|
|
|
|
|
|
|
|
|
| Pediatric (Age
< 18) |
|
|
|
|
|
|
|
|
Transplants (n) 1 |
8 |
8 |
6 |
|
68 |
68 |
89 |
|
Patient Survival (%) 2 |
75.00 |
75.00 |
100.00 |
|
95.31 |
83.10 |
54.77 |
|
Expected Patient Survival (%) 3 |
- |
- |
- |
|
NA |
NA |
NA |
|
P-value (2-sided) 4 |
- |
- |
- |
|
NA |
NA |
NA |
|
Statistically different from expected |
- |
- |
- |
|
NA |
NA |
NA |
|
Follow-up days reported (%) 5 |
52.4 |
30.7 |
53.6 |
|
91.9 |
85.5 |
88.7 |
|
Maximum Days of Follow-up (n) |
30 |
365 |
1,096 |
|
30 |
365 |
1,096 |
|
Follow-up forms filed (%) 6 |
87.5 |
87.5 |
100.0 |
|
98.5 |
98.5 |
98.9 |
| |
|
|
|
|
|
|
|
|
| Transplant Time Period |
7/1/98-6/30/00 |
7/1/98-6/30/00 |
7/1/96-6/30/98 |
|
7/1/98-6/30/00 |
7/1/98-6/30/00 |
7/1/96-6/30/98 |
| 1 Transplants during
the time period indicated in the last row of the table. |
| 2 Because different
cohorts are followed for each time period, it is possible for reported 3-year
survival to exceed 1-year survival. |
| 3 Based on U.S.
patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. |
| 4 A
p-value less than or equal to 0.05 indicates that the difference between the
actual and expected patient survival is probably real and is not due to
random chance, while a p-value greater than 0.05 indicates that the
difference could possibly be due to random chance. |
| 5 Of
days expected to be included in the follow-up period, the percentage of days
covered by follow-up reporting for these tranplants. A low percent may indicate a
non-representative sample from this facility for followup. This measures the possibility that events
such as failure have occurred without being reported, and it is not a measure
of compliance. |
| 6
Percent of 3 month follow-up forms filed is used for 1 month survival;
percent of 1 year follow-up forms filed is used for 1 year survival; and
percent of 3 year follow-up forms filed is used for 3 year survival. |
| Based on data available as of 11/01/2001. |
|
|
|
|
|
|
|
|
|
